Susan Perlman, MD is a graduate of Cornell University and the State University of New York at Stony Brook School of Medicine. She did an internship in medicine, her residency in neurology, and a two-year fellowship in Friedreich's Ataxia at UCLA Medical Center. Dr. Perlman is currently a Clinical Professor of Neurology and has been Director of the Ataxia Center at the UCLA Medical Center in Los Angeles, CA, since 1983. She has worked in Ataxia diagnosis for over 30 years and has networked with other "Ataxologists" across the country and around the world, trying to build better collaboration in the development to treatments and ultimately cures. She helped develop the National Ataxia Database for clinical research. She is participating in 6 natural history studies (for Spinocerebellar Ataxia, Friedreich's Ataxia, and other ataxias) and has participated in nearly 24 clinical drug trials. Dr. Perlman would like to expand the work being done in non-genetic Ataxia as well. Dr. Perlman authored Evaluation and Management of Ataxic Disorders: An Overview for Physicians, which has become a valuable resource for NAF. She serves on NAF's Medical Research Advisory Board and is an ex-officio member of NAF's Board of Directors.
Cure Rare Disease, a non-profit organization (Tax ID number 82-2473513), is qualified as a tax-exempt organization under section 501(c)(3) of the IRS and has been designated as a “public charity” under section 170.
